Abstract
In 1989 an estimated 104,000 cases of prostatic adenocarcinoma will account for about 20% of all male cancers and 11% of all male cancer-related deaths in the U.S.A. As the U.S. population ages, the incidence of this specific tumor type, which is most common in males over 50 years of age, will increase substantially. Prostatic cancers display widely-varying growth rates which impact on the prognosis and required therapeutic intervention. Histologic examination of tumor types is widely used to correlate morphology with growth rates, but there are still histologically-similar tumors which vary markedly in growth characteristics. Neoplasia differs from normal cellular growth in the expression of one or more genes, a feature of cancer which can result in an altered metabolism of tumor cells. We are using Nuclear Magnetic Resonance Spectroscopy (NMRS), a non-invasive and non-destructive method for observing metabolic events both in vitro and in vivo (1–22), to elucidate these metabolic alterations in prostate tumors with the goal of improving our basic understanding of the oncogenetic process in this organ.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sillerud LO, Han CH, Bitensky MW, Francendese AA: Metabolism and structure of triacylglycerols in rat epididymal fat pad adipocytes determined by 13C nuclear magnetic resonance. J. Biol. Chem. 261:4380–4388, 1986.
Sillerud LO, Shulman RG: Structure and metabolism of mammalian liver glycogen monitored by 13C nuclear magnetic resonance. Biochemistry 22:1087–1094, 1983.
Sillerud LO, Heyser JW, Han CH, Bitensky MW: Applications of carbon-13 and sodium-23 NMR in the study of plants, animal, and human cells. In: NMR in Living Systems, T Axenrod and G Ceccarelli (eds), Reidel, Boston, pp. 309–333, 1986.
Scott AI, Baxter RL: Applications of 13C NMR to metabolic studies. Ann. Rev. Biophys. Bioeng. 10:151–174, 1981.
Radda GK, Taylor DJ: Applications of nuclear magnetic resonance spectroscopy in pathology. In: Int. Rev. Exp. Path., Vol. 27, Academic Press Inc., New York, pp. 1–58, 1985.
Chan L: The current status of magnetic resonance spectroscopy: Basic and clinical aspects. West. J. Med. 143:773–781, 1985.
Avison MJ, Hetherington HP, Shulman RG: Applications of NMR to studies of tissue metabolism. Ann. Rev. Biophys. Chem. 15:377–402, 1986.
Radda GK: The use of NMR spectroscopy for the understanding of disease. Science 233:640–645, 1986.
Gupta RK: In: NMR Spectroscopy of Cells and Organisms, Vols. I & II, CRC Press Inc., Boca Raton, FL, 1987.
Sostman HD, Armitage IM, Fischer JJ: NMR in cancer. I. High resolution of tumors. Magn. Reson. Imag. 42:265–278, 1984.
Evanochko WT, Ng TC, Glickson JD: Application of in vivo NMR spectroscopy to cancer. Magn. Reson. Med. 1:508–534, 1984.
Maris JM, Chance B: Magnetic resonance spectroscopy of neoplasms. In: Magnetic Resonance Annual 1986, HY Kressel (ed), Raven Press, New York, pp. 213–235, 1986.
Wehrle JP, Glickson JD: 31P NMR spectroscopy of tumors in vivo. Cancer Biochem. Biophys. 8:157–166, 1986.
Glickson JD, Evanochko TT, Sakai TT, Ng TC: In vivo NMR spectroscopy of tumors. In: NMR Spectroscopy of Cells and Organisms, Vol. 1, RK Gupta (ed), CRC Press Inc., Boca Raton, FL, pp. 99–134, 1987.
Cohen SM: Application of nuclear magnetic resonance to the study of liver physiology and disease. Hepatology 3:738–749, 1983.
Roberts JKM, Jardetzky O: Monitoring of cellular metabolism by NMR. Biochim. Biophys. Acta. 639:53–76, 1981.
Shulman RG, Brown TR, Ugurbil K et al: Cellular application of 31P and 13C nuclear magnetic resonance. Science 205:160–166, 1979.
Yoshikawa K, Ohsaka A: 1H and 13C NMR spectroscopic study of rat organs. Physiol. Chem. Phys. 12:515–520, 1980.
Iles RA, Stevens AN, Griffith JR: NMR studies of metabolites in living tissue. Prog. Nucl. Magn. Reson. Spectros. 15: 49–200, 1982.
Foster MA: Magnetic Resonance in Medicine and Biology, Pergamon Press, Elmsford, NY, 1983.
Halliday KR, Sillerud LO, Fenoglio-Preiser C: Carbon-13 and proton nuclear magnetic resonance spectroscopy and microscopy of neoplasms. In: Adv. Pathol., Vol. 2, C Fenoglio-Preiser (ed), Year Book Medical Publishers, Chicago, pp. 213–257, 1988.
Halliday KR, Fenoglio-Preiser C, Sillerud LO: Differentiation of human tumors from non-malignant tissue by natural abundance 13C NMR spectroscopy. Magn. Reson. Med. 7:384–411, 1988.
Jue T, Lohman JAB, Ordidge RJ, Shulman RG: Natural abundance 13C NMR spectrum of glycogen in humans. Magn. Reson. Med. 5:377–379, 1987.
Tavitian BA, Jue T, Rothman DL, Shulman RG: Observing human hepatic and muscle glycogen metabolism with 13C NMR. 2nd European Congress of NMR in Medicine and Biology, Berlin, West Germany, Abstract P92, 1988.
Alger JR, Sillerud LO, Behar KL et al: In vivo 13C nuclear magnetic resonance studies of mammals. Science 241:660–662, 1981.
Sillerud LO, Halliday KR, Griffey RH et al: In vivo 13C NMR spectroscopy of the human prostate. Magn. Reson. Med. 8:224–230, 1988.
Heerschap A, Luyten PR, van der Heyden JI et al: Broadband proton decoupled natural abundance 13C NMR spectroscopy of humans at 1.5T. NMR in Biomedicine 2:1–9, 1989.
Halliday KR, Fenoglio-Preiser C, van der Kogel B, Sillerud LO: Differentiation of tumor from normal human tissue by natural-abundance 13C NMR. Abstr. Soc. Magn. Reson. Med. 5:149–150, 1986.
Halliday KR, Fenoglio-Preiser C, Sillerud LO: Differentiation of tumor from non-malignant human tissue by natural -abundance 13C NMR in vitro. Annuals. New York Acad. Sci. 508:469–471, 1987.
Halliday KR, Fenoglio-Preiser C, Han CH, Sillerud LO: Diagnosis of gastric and colonic adenocarcinomas by natural abundance 13C NMR spectroscopy. Abstr. Soc. Magn. Reson. Med. 6:503–504, 1987.
Halliday KR, Mickey DD, Fenoglio-Preiser C et al: In vitro 13C NMR spectroscopy of Dunning rat prostatic tumors. Abstr. Soc. Magn. Reson. Med. 7:494, 1988.
Halliday KR, Clinard EH, Hutson JY et al: Metabolism of perfused AT-1 spheroids derived from prostate tumors monitored by 13C and 31P NMR spectroscopy. Abstr. Soc. Magn. Reson. Med. 8: #151, 1989.
Sillerud LO, Freyer JP, Mattingly M: Proton NMR microscopy of multi-cellular tumor spheroid microphysiology. Magn. Reson. Med., in press.
Diem K, Lentner C (eds), Geigy Scientific Tables, 7th Edition, Ciba-Geigy Limited, Basel, Switzerland, p. 685, 1970.
Cooper JF, Farid I: The role of citric acid in the physiology of the prostate. III. Lactate/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. J. Urol. 92:533–536, 1964.
Marberger H, Marberger E, Mann T, Lutwak-Mann C: Citric acid in human prostatic secretion and metastasizing cancer of prostate gland. Brit. Med. J. March 24:835–836, 1962.
Costello LC, Littleton GK, Franklin RB: Regulation of citrate-related metabolism in normal and neoplastic prostate. In: Endocrine Control in Neoplasis, RK Sharma and WE Criss (eds), Raven Press, New York, pp. 303–314, 1978.
Brauenstein H: Staining lipid in carcinoma of the prostate gland. Amer. J. Clin. Path. 41:44–48, 1964.
Hall M, Silverman L, Wenger AS, Mickey DD: Oncodevelopmental enzymes of the Dunning rat prostatic adenocarcinoma. Cancer Res. 45:4053–4059, 1985.
Isaacs JT, Heston WDW, Weissman RM, Coffey DS: Animal model of hormone sensitive and insensitive prostatic adenocarcinomas: Dunning R-3327-H, R-3327-HI, and R-3327-AT. Cancer Res. 38:4353–4359, 1978.
Freyer JP, Sutherland RM: Selective dissociation and characterization of cells from different regions of multiceli tumor spheroids. Cancer Res. 40:3956–3965, 1980.
Sutherland RM, Durand RE: Growth and cellular characteristics of multiceli spheroids. In: Recent Results in Cancer Research. Spheroids in Cancer Research: Methods and Perspectives, Vol. 95, H Acker, J Carlsson, R Durand and RM Sutherland (eds), Springer Verlag, New York, pp. 24–49, 1984.
Freyer JP, Fink NH, Schor PL et al: A system for viably maintaining a stirred suspension of multicellular spheroids during NMR spectroscopy. NMR in Biomedicine, in press.
Bottomley PA, Roemer PB: Local RF power deposition in tissue is elevated in 1H NMR decoupling experiments employing surface coils. Abstr. Soc. Magn. Reson. Med. 8: #997, 1989.
Shulman GI, Rothman DL, Jue T et al: Differences of muscle glycogen synthesis between normal men and noninsulin dependent diabetics measured directly by 13C NMR spectroscopy. Abstr. Soc. Magn. Reson. Med. 8: #299, 1989.
Sillerud LO, van Hulsteyn DB, Griffey RH: {13C}-polariza-tion transfer proton NMR imaging of a sodium [13C]-formate phantom at 4.7T. J. Magn. Reson. 76:380–385, 1988.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Sillerud, L.O., Halliday, K.R., Freyer, J.P., Griffey, R.H., Fenoglio-Preiser, C. (1990). 13C and 31P NMR Studies of Prostate Tumor Metabolism. In: Evelhoch, J.L., Negendank, W., Valeriote, F.A., Baker, L.H. (eds) Magnetic Resonance in Experimental and Clinical Oncology. Developments in Oncology, vol 61. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0691-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0691-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8028-6
Online ISBN: 978-1-4613-0691-7
eBook Packages: Springer Book Archive